Abstract
2′‐Deoxyadenosine triphosphate (dATP) derivatives bearing diverse substituents (Cl, NH2, CH3, vinyl, ethynyl, and phenyl) at position 2 were prepared and tested as substrates for DNA polymerases. The 2‐phenyl‐dATP was not a substrate for DNA polymerases, but the dATPs bearing smaller substituents were good substrates in primer‐extension experiments, producing DNA substituted in the minor groove. The vinyl‐modified DNA was applied in thiol–ene addition and the ethynyl‐modified DNA was applied in a CuAAC click reaction to form DNA labelled with fluorescent dyes in the minor groove
Keywords: bioconjugation, DNA modification, DNA polymerase, nucleotides, fluorescent labelling
Base‐modified oligonucleotides (ONs) or DNA are widely used as tools in chemical biology, diagnostics, or materials science.1 The modification is mostly attached to position 5 of pyrimidines or position 7 of 7‐deazapurines, not only because it then points out into the major groove of DNA and thus does not destabilize the duplex, but because in most cases, the corresponding substituted 2′‐deoxyribonucleoside triphosphates (dNTPs) are good substrates for DNA polymerases and can be used in the polymerase‐catalyzed synthesis of modified DNA.2, 3 Diverse modifications, including fluorophores,4 redox5 or spin labels,6 reactive groups for conjugations,7 and biomolecules (e.g., oligonucleotides8 or proteins9), have been introduced into the major groove through the enzymatic incorporation of modified nucleotides and applied in different fields. Modification or labelling of the minor groove has mostly been reported with 2′‐ and 4′‐sugar‐modified derivatives.10, 11, 12, 13 2‐Chloroadenine14 and 2,6‐diaminopurine15 dNTPs are the only minor‐groove base‐modified nucleotides that have been reported as substrates for DNA polymerases, whereas 2‐arylamino‐dATP derivatives were found to act as polymerase inhibitors.16 The minor groove sites of the nucleobases are difficult to modify since they are crucial both for Watson–Crick base pairing and for key minor‐groove interactions with DNA polymerase that are important for extension of the chain.17 On the other hand, 2‐ethynylpyridone‐C‐nucleotide incorporated into DNA18 formed a stable base pair with adenine, and 2‐(imidazolylalkylamino)purines in ONs also stabilized duplexes.19 Because the possibility of minor‐groove base labelling would be attractive for many prospective applications, for example, the mapping of DNA–protein interactions, we envisaged that a small substituent at position 2 of a purine may not fully disturb the key H‐bonding interactions with the opposite base and the polymerase, and we report herein the first enzymatic synthesis of minor‐groove base‐modified DNA.
A series of six 2‐substituted dATP derivatives bearing Cl, NH2, CH3, vinyl, ethynyl and phenyl substituents (dRATPs) was designed to study the effect of substituents of different bulkiness at position 2 of adenine on polymerase‐mediated incorporation. While dClATP 14, 20 and dNH2ATP 15 were known, the others were prepared through triphosphorylation21 of the corresponding 2′‐deoxy‐ribonucleosides (dRAs, Scheme 1), which were synthesized through cross‐coupling reactions of the 2‐iodo‐2′‐deoxyadenosine (for details of the synthesis, see the Supporting Information).
Scheme 1.

a) Synthesis of 2‐substituted dATP derivatives. b) PEX incorporation of the modified nucleotides into DNA. c, d) Post‐synthetic minor‐groove fluorescent labelling by thiol–ene (c) or CuAAC (d) reactions.
The dRATPs were then tested as substrates for DNA polymerases in primer extension (PEX) experiments. First, we performed PEX in presence of KOD XL, Vent(exo‐), or Bst DNA polymerase, using a 15‐nt primer (prim248short) and 19‐nt template (tempoligo1A) designed for the incorporation of one modified nucleotide, and the outcome was analyzed by denaturing polyacrylamide gel electrophoresis (PAGE). All three DNA polymerases (Figure 1 a and Figure S1 in the Supporting Information) incorporated the 2‐substituted deoxyadenosine nucleotides, giving clean full‐length DNA products (DNA1RA). The only exception was the 2‐phenyl derivative dPhATP, which apparently was not a substrate for DNA polymerases since almost no extension was observed. Then PEX was conducted using a longer 31‐nt template (tempPrb4basII, which is modified with TINA at 3′‐end to prevent non‐templated incorporation,22 Figure 1 b and Figure S2) designed for the incorporation of 4 R A modifications. Most of the modified dRATPs were good substrates, giving full‐length products (DNA4RA). Only the PEX product from ethynylated dEATP and KOD XL DNA polymerase was partially halted at the n−1 position (but Vent(exo‐) and Bst DNA polymerases gave clean full‐length products; see Figure S2), while dPhATP did not give PEX with any of the tested DNA polymerases. All of the PEX experiments (with all of the dRATPs and both templates) with KOD XL DNA polymerase were repeated using biotinylated templates, and the modified single‐stranded oligonucleotides (ONs, ON1RA or ON4RA) were isolated by magnetoseparation23 and analyzed by MALDI‐TOF, which confirmed their identity (Table S2 in the Supporting Information).
Figure 1.

a, b) Denaturating PAGE of PEX experiments in presence of KOD XL with tempoligo1A (a) or tempPrb4basII‐TINA (b). P: primer, +: products of PEX with natural dNTPs, A−: products of PEX with dTTP, dCTP, and dGTP; RA: products of PEX with dTTP, dCTP, dGTP, and functionalized dRATP. c) PAGE analyses of the kinetics of single‐nucleotide extension experiments with temp1A term, KOD XL, and dRATP compared to natural dATP. Time intervals are given in minutes.
To further quantify the substrate activities of the modified dRATPs, we conducted a simple kinetic analysis of single‐nucleotide extension using KOD XL DNA polymerase and temp1A_term (Figure 1 c) and compared the conversion as a function of time to that observed with natural dATP. The rate of extensions when using the smaller derivatives dClATP, dNH2ATP, or dMeATP were comparable to the rate with natural dATP, whereas PEX with the bulkier dVATP and dEATP took approximately 2 min to reach completion. To study the influence of the 2‐modifications on the base pairing and duplex stability, we measured the denaturing temperatures of all of the PEX products (Table 1). Except for 2,6‐diaminopurine, which stabilized the dsDNA due to an additional H‐bond with T, all of the other modifications destabilized the duplexes.
Table 1.
Denaturing temperatures of modified DNA duplexes.
| DNA | T m [°C] | ΔT m [°C][a] | DNA | T m [°C] | ΔT m [°C][a] |
|---|---|---|---|---|---|
| DNA1A | 72.2 | – | DNA4A | 79.4 | – |
| DNA1ClA | 69.6 | −2.6 | DNA4ClA | 71.0 | −2.1 |
| DNA1NH2A | 72.5 | +0.3 | DNA4NH2A | 81.4 | +0.5 |
| DNA1MeA | 70.5 | −1.7 | DNA4MeA | 72.3 | −1.8 |
| DNA1VA | 66.6 | −5.6 | DNA4VA | 72.6 | −1.7 |
| DNA1EA | 66.1 | −6.1 | DNA4EA | 71.1 | −2.1 |
| DNA1Cy3A | 69.0 | −3.2 |
[a] ΔT m=(T m mod−T m natur)/n mod
With the shorter (DNA1VA or DNA1EA) and longer (DNA4VA or DNA4EA) dsDNA containing one or four 2‐vinyl‐ or 2‐ethynyladenine modifications in hand, we tested whether they could be used for post‐synthetic minor‐groove fluorescence labelling. The vinyl group was envisaged for use in the thiol–ene reaction (Scheme 1 c),24 whereas the ethynyl group was envisaged for use in Cu‐catalyzed alkyne–azide cycloaddition (CuAAC; Scheme 1 d).25 We selected coumarinemethylthiol (CM‐SH)26 and the commercially available azide‐conjugated Cy3 (Cy3‐N3) as model reagents. The thiol–ene reactions of DNA1VA or DNA4VA with CM‐SH proceeded in 3 days at 37 °C without UV irradiation to give approximately 60 % conversion (based on PAGE analysis, Figure 2 d) to blue‐fluorescent conjugates (DNA1CMA or DNA4CMA; Figure 2 a,c). In this case, UV irradiation did not help, owing to bleaching of the fluorophore. The CuAAC reactions of DNA1EA or DNA4EA with Cy3‐N3 proceeded smoothly at 37 °C in the presence of CuBr, sodium ascorbate, and tris(benzyltriazolylmethyl)amine (TBTA), quantitatively providing the red‐fluorescent Cy3‐triazole‐modified DNA (DNA1Cy3A or DNA4Cy3A; Figure 2 b,e,f). Interestingly, the triazole‐linked duplex was more stable than the starting ethynyl‐modified DNA (Table 1).
Figure 2.

a) Normalized emission spectra of DNA1VA and DNA4VA compared to non‐modified DNA1A or DNA4A before and after thiol–ene reaction with CM‐SH. b) Normalized emission spectra of DNA1EA and DNA4EA compared to non‐modified DNA1A or DNA4A before and after CuAAC reaction with Cy3‐N3. c) A photograph of vials containing CM‐linked DNA under UV irradiation (365 nm) compared to non‐modified DNA treated with the same reagent. d) PAGE analysis of PEX product ON1VA and the product of subsequent thiol–ene reaction, ON1CMA. e) A photograph of vials containing Cy3‐linked DNA (in H2O/glycerol) under UV irradiation (365 nm) compared to non‐modified DNA treated with the same reagent. f) PAGE analysis of PEX product ON1EA and the product of subsequent CuAAC reaction, ON1Cy3A.
In conclusion, we found that not only 2‐chloro‐14 and 2‐aminoadenine15 dNTPs, but also dATP derivatives bearing smaller C substituents at position 2 (CH3, vinyl, and ethynyl) are good substrates for DNA polymerases and can be used for the enzymatic synthesis of base‐modified DNA bearing substituents in the minor groove. Conversely, the phenyl group is too bulky because the corresponding dPhATP was not a substrate for any tested DNA polymerase. The minor‐groove vinyl‐ or ethynyl‐modified DNAs can be post‐synthetically labelled through thiol–ene or CuAAC reactions with thiols or azides, which was exemplified by fluorescent labelling with coumarine or Cy3. To the best of our knowledge, this is the first example of polymerase‐catalyzed synthesis of DNA modified at the minor groove sites of nucleobases, and it paves the way for other minor‐groove nucleobase modifications and conjugations,27 which could be useful in applications in chemical biology or imaging. Studies along these lines are underway.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
Acknowledgements
This work was supported by the Czech Academy of Sciences (RVO: 61388963 and the Praemium Academiae award to M. H.), by the Czech Science Foundation (14‐04289S to M.H.) by the Marie Sklodowska‐Curie Innovative Training Network (ITN) Click Gene (H2020‐MSCA‐ITN‐2014‐642023 to J.M.).
J. Matyašovský, P. Perlíková, V. Malnuit, R. Pohl, M. Hocek, Angew. Chem. Int. Ed. 2016, 55, 15856.
Contributor Information
Ján Matyašovský, http://www.uochb.cas.cz/hocekgroup.
Prof. Dr. Michal Hocek, Email: hocek@uochb.cas.cz.
References
- 1. Modified Nucleic Acids, Nucleic Acids and Molecular Biology Series, Vol. 31 (Eds.: K. Nakatani, Y. Tor), Springer, Berlin, 2016, pp. 1–276. [Google Scholar]
- 2.Reviews:
- 2a. Hottin A., Marx A., Acc. Chem. Res. 2016, 49, 418–427; [DOI] [PubMed] [Google Scholar]
- 2b. Hollenstein M., Molecules 2012, 17, 13569–13591; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2c. Hocek M., J. Org. Chem. 2014, 79, 9914–9921; [DOI] [PubMed] [Google Scholar]
- 2d. Kuwahara M., Sugimoto N., Molecules 2010, 15, 5423–5444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Recent examples:
- 3a. Obeid S., Baccaro A., Welte W., Diederichs K., Marx A., Proc. Natl. Acad. Sci. USA 2010, 107, 21327–21331; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3b. Bergen K., Steck A. L., Strütt S., Baccaro A., Welte W., Diederichs K., Marx A., J. Am. Chem. Soc. 2012, 134, 11840–11843; [DOI] [PubMed] [Google Scholar]
- 3c. Kielkowski P., Fanfrlík J., Hocek M., Angew. Chem. Int. Ed. 2014, 53, 7552–7555; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2014, 126, 7682–7685. [Google Scholar]
- 4.Recent examples:
- 4a. Dziuba D., Jurkiewicz P., Cebecauer M., Hof M., Hocek M., Angew. Chem. Int. Ed. 2016, 55, 174–178; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2016, 128, 182–186; [Google Scholar]
- 4b. Dziuba D., Pospíšil P., Matyašovský J., Brynda J., Nachtigallová D., Rulíšek L., Pohl R., Hof M., Hocek M., Chem. Sci. 2016, 7, 5775–5785; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4c. Tokugawa M., Masaki Y., Canggadibrata J. C., Kaneko K., Shiozawa T., Kanamori T., Grøtli M., Wilhelmsson L. M., Sekine M., Seio K., Chem. Commun. 2016, 52, 3809–3812. [DOI] [PubMed] [Google Scholar]
- 5.
- 5a. Balintová J., Plucnara M., Vidláková P., Pohl R., Havran L., Fojta M., Hocek M., Chem. Eur. J. 2013, 19, 12720–12731; [DOI] [PubMed] [Google Scholar]
- 5b. Balintová J., Špaček J., Pohl R., Brázdová M., Havran L., Fojta M., Hocek M., Chem. Sci. 2015, 6, 575–587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Obeid S., Yulikov M., Jeschke G., Marx A., Angew. Chem. Int. Ed. 2008, 47, 6782–6785; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008, 120, 6886–6890. [Google Scholar]
- 7.
- 7a. Weisbrod S. H., Marx A., Chem. Commun. 2007, 1828–1830; [DOI] [PubMed] [Google Scholar]
- 7b. Borsenberger V., Howorka S., Nucleic Acids Res. 2009, 37, 1477–1485; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7c. Schoch J., Wiessler M., Jäschke A., J. Am. Chem. Soc. 2010, 132, 8846–8847; [DOI] [PubMed] [Google Scholar]
- 7d. Gutsmiedl K., Fazio D., Carell T., Chem. Eur. J. 2010, 16, 6877–6883; [DOI] [PubMed] [Google Scholar]
- 7e. Raindlová V., Pohl R., Hocek M., Chem. Eur. J. 2012, 18, 4080–4087; [DOI] [PubMed] [Google Scholar]
- 7f. Dadová J., Orság P., Pohl R., Brázdová M., Fojta M., Hocek M., Angew. Chem. Int. Ed. 2013, 52, 10515–10518; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 10709–10712; [Google Scholar]
- 7g. Arndt S., Wagenknecht H. A., Angew. Chem. Int. Ed. 2014, 53, 14580–14582; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2014, 126, 14808–14811; [Google Scholar]
- 7h. Wang K., Wang D., Ji K., Chen W., Zheng Y., Dai C., Wang B., Org. Biomol. Chem. 2015, 13, 909–915; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7i. Ren X., El-Sagheer A. H., Brown T., Nucleic Acids Res. 2016, 44, e79; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7j. Olszewska A., Pohl R., Brázdová M., Fojta M., Hocek M., Bioconjugate Chem. 2016, 27, 2089–2094. [DOI] [PubMed] [Google Scholar]
- 8. Baccaro A., Steck A. L., Marx A., Angew. Chem. Int. Ed. 2012, 51, 254–257; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012, 124, 260–263. [Google Scholar]
- 9. Welter M., Verga D., Marx A., Angew. Chem. Int. Ed. 2016, 55, 10131–10135; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2016, 128, 10286–10290. [Google Scholar]
- 10.
- 10a. Rubner M. M., Holzhauser C., Bohländer P. R., Wagenknecht H. A., Chem. Eur. J. 2012, 18, 1299–1302; [DOI] [PubMed] [Google Scholar]
- 10b. Berndl S., Herzig N., Kele P., Lachmann D., Li X., Wolfbeis O. S., Wagenknecht H. A., Bioconjugate Chem. 2009, 20, 558–564. [DOI] [PubMed] [Google Scholar]
- 11. Wenge U., Ehrenschwender T., Wagenknecht H. A., Bioconjugate Chem. 2013, 24, 301–304. [DOI] [PubMed] [Google Scholar]
- 12.
- 12a. Lauridsen L. H., Rothnagel J. A., Veedu R. N., ChemBioChem 2012, 13, 19–25; [DOI] [PubMed] [Google Scholar]
- 12b. Kuwahara M., Obika S., Nagashima J., Ohta Y., Suto Y., Ozaki H., Sawai H., Imanishi T., Nucleic Acids Res. 2008, 36, 4257–4265; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12c. Chen T., Hongdilokkul N., Liu Z., Adhikary R., Tsuen S. S., Romesberg F. E., Nat. Chem. 2016, 8, 556–562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Marx A., MacWilliams M. P., Bickle T. A., Schwitter U., Giese B., J. Am. Chem. Soc. 1997, 119, 1131–1132. [Google Scholar]
- 14. Parker W. B., Shaddix S. C., Chang C.-H., White E. L., Rose L. M., Brockman R. W., Shortnacy A. T., Montgomery J. A., J. A. Secrist III , Bennett L. L., Cancer Res. 1991, 51, 2386–2394. [PubMed] [Google Scholar]
- 15.
- 15a. Chollet A., Kawashima E., Nucleic Acids Res. 1988, 16, 305–317; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15b. Kutyavin I. V., Biochemistry 2008, 47, 13666–13673. [DOI] [PubMed] [Google Scholar]
- 16.
- 16a. Khan N. N., Wright G. E., Dudycz L. W., Brown N. C., Nucleic Acids Res. 1985, 13, 6331–6342; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16b. Zdrazil B., Schwanke A., Schmitz B., Schäfer-Korting M., Höltje H. D., J. Enzyme Inhib. Med. Chem. 2011, 26, 270–279. [DOI] [PubMed] [Google Scholar]
- 17. Matsuda S., Leconte A. M., Romesberg F. E., J. Am. Chem. Soc. 2007, 129, 5551–5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Minuth M., Richert C., Angew. Chem. Int. Ed. 2013, 52, 10874–10877; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 11074–11077. [Google Scholar]
- 19. Ramasamy K. S., Zounes M., Gonzales C., Freier S. M., Lesnik E. A., Cummins L. L., Griffey R. H., Monia B. P., Cook P. D., Tetrahedron Lett. 1994, 35, 215–218. [Google Scholar]
- 20. D′Ambrosi N., Constanzi S., Angelini D. F., Volpini R., Sancesario G., Cristalli G., Volonte C., Biochem. Pharmacol. 2004, 67, 621–630. [DOI] [PubMed] [Google Scholar]
- 21. Kovács T., Ötvös L., Tetrahedron Lett. 1988, 29, 4525–4528. [Google Scholar]
- 22. Güixens-Gallardo P., Hocek M., Perlíková P., Bioorg. Med. Chem. Lett. 2016, 26, 288–291. [DOI] [PubMed] [Google Scholar]
- 23. Brázdilová P., Vrábel M., Pohl R., Pivonková H., Havran L., Hocek M., Fojta M., Chem. Eur. J. 2007, 13, 9527–9533. [DOI] [PubMed] [Google Scholar]
- 24.
- 24a. Hoyle C. E., Bowman C. N., Angew. Chem. Int. Ed. 2010, 49, 1540–1573; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2010, 122, 1584–1617; [Google Scholar]
- 24b. Hoyle C. E., Lowe A. B., Bowman C. N., Chem. Soc. Rev. 2010, 39, 1355–1387. [DOI] [PubMed] [Google Scholar]
- 25.
- 25a. Gramlich P. M. E., Wirges C. T., Manetto A., Carell T., Angew. Chem. Int. Ed. 2008, 47, 8350–8358; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008, 120, 8478–8487; [Google Scholar]
- 25b. El-Sagheer A. H., Brown T., Chem. Soc. Rev. 2010, 39, 1388–1405. [DOI] [PubMed] [Google Scholar]
- 26. Akita S., Umezawa N., Higuchi T., Org. Lett. 2005, 7, 5565–5568. [DOI] [PubMed] [Google Scholar]
- 27. Merkel M., Peewasan K., Arndt S., Ploschik D., Wagenknecht H. A., ChemBioChem 2015, 16, 1541–1553. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
